Latest in Vaccines and Checkups

finance.yahoo.com
858 words

Blue Lake Biotechnology Secures $5 Million Grant to Support Ongoing Pediatric Phase 1/2a Clinical Trial of Intranasal RSV Vaccine Candidate

Funding will increase enrollment of children as young as 12 months old and explore the potential for BLB201 to reduce RSV transmissionATHENS, Ga. and SAN JOSE, Calif., Oct. 28, 2026 (GLOBE NEWSWIRE) -- Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company developing parainfluenza virus…

Vaccines and Checkups

Vaccines and Checkups in Babies: the news, the names and what changed.

  • 11 Tracked terms
  • Last 30 days Feed window

What this topic collects on

An article joins this feed when it matches these terms. Each one is also a search of its own.